Brazil’s União Química completes first batch of Russian Covid-19 Sputnik V vaccine

Moscow's Gamaleya Institute, which developed the vaccine, said it was in charge of the quality control of the vaccine's ingredients, which was bottled at União Química's unit in the city of Guarulhos, São Paulo

RIO DE JANEIRO, BRAZIL - União Química has completed the production of its first batch of the Sputnik V coronavirus vaccine with active ingredients and technology supplied by Russia, the Brazilian pharmaceutical company announced Thursday, May 20.

The vaccine will be exported to neighboring South American countries, as Brazil's health regulator ANVISA has not authorized the Russian vaccine for domestic use.

Moscow's Gamaleya Institute, which developed the vaccine, said it was in charge of the quality control of the vaccine's ingredients, which was bottled at União Química's unit in the city of Guarulhos . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?